WATCH: Marija Balic, MD, PhD, discusses the potential role of tumor-informed ctDNA testing in early triple-negative breast cancer based on findings from a sub-study of the NSABP B-59/GBG-96-GeparDouze trial.
@UPMCHillmanCC

@AACR
#bcsm #oncology

See our coverage of the #AACR26